Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 6;32(11):3955-3973.
doi: 10.1016/j.ymthe.2024.09.022. Epub 2024 Sep 17.

Therapeutic CRISPR epigenome editing of inflammatory receptors in the intervertebral disc

Joshua D Stover  1 , Matthew A R Trone  1 , Jacob Weston  1 , Christian Lewis  1 , Hunter Levis  1 , Niloofar Farhang  1 , Matthew Philippi  2 , Michelle Zeidan  2 , Brandon Lawrence  3 , Robby D Bowles  4
Affiliations

Therapeutic CRISPR epigenome editing of inflammatory receptors in the intervertebral disc

Joshua D Stover et al. Mol Ther. .

Abstract

Low back pain (LBP) ranks among the leading causes of disability worldwide and generates a tremendous socioeconomic cost. Disc degeneration, a leading contributor to LBP, can be characterized by the breakdown of the extracellular matrix of the intervertebral disc (IVD), disc height loss, and inflammation. The inflammatory cytokine tumor necrosis factor α (TNF-α) has multiple signaling pathways, including proinflammatory signaling through tumor necrosis factor receptor 1 superfamily, member 1a (TNFR1 or TNFRSF1A), and has been implicated as a primary mediator of disc degeneration. We tested our ability to regulate the TNFR1 signaling pathway in vivo, utilizing CRISPR epigenome editing to slow the progression of disc degeneration in rats. Sprague-Dawley rats were treated with TNF-α and CRISPR interference (CRISPRi)-based epigenome-editing therapeutics targeting TNFR1, showing decreased behavioral pain in a disc degeneration model. Surprisingly, while treatment with the vectors alone was therapeutic, the TNF-α injection became therapeutic after TNFR1 modulation. These results suggest direct inflammatory receptor modulation as a potent strategy for treating disc degeneration.

Keywords: CRISPR; TNFR1; degenerative disc disease; gene therapy; inflammatory cytokine signaling; intervertebral disc; low back pain.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Update of

References

    1. Frymoyer J.W. Back Pain and Sciatica. N. Engl. J. Med. 1988;318:291–300. doi: 10.1056/NEJM198802043180506. - DOI - PubMed
    1. Vos T., Barber R.M., Bell B., Bertozzi-Villa A., Biryukov S., Bolliger I., Charlson F., Davis A., Degenhardt L., Dicker D., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. doi: 10.1016/S0140-6736(15)60692-4. - DOI - PMC - PubMed
    1. Murray C.J.L., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4. - DOI - PubMed
    1. Katz J.N. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J. Bone Joint Surg. Am. 2006;88:21–24. doi: 10.2106/JBJS.E.01273. - DOI - PubMed
    1. Luoma K., Riihimäki H., Luukkonen R., Raininko R., Viikari-Juntura E., Lamminen A. Low Back Pain in Relation to Lumbar Disc Degeneration. Spine (Phila Pa 1976) 2000;25:487–492. - PubMed

MeSH terms

Substances

LinkOut - more resources